Relmada Therapeutics, Inc. (RLMD)
5.71
-0.24
(-4.03%)
USD |
NASDAQ |
Jun 08, 16:00
5.79
+0.08
(+1.40%)
After-Hours: 20:00
Relmada Therapeutics Market Cap : 598.92M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Theravance Biopharma, Inc. | 839.69M |
| Indivior Pharmaceuticals, Inc. | 4.564B |
| ANI Pharmaceuticals, Inc. | 1.834B |
| Corcept Therapeutics, Inc. | 7.871B |
| Assertio Holdings, Inc. | 151.04M |
Market Cap Related Metrics
| Price to Book Value | 2.738 |
| Price | 5.71 |
| Earnings Yield | -19.48% |